SCHEMBL6506891

SCHEMBL6506891

CCCC[Si](C)(C)OCc1ccccc1C(=O)N(C)OC

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.38
HTT P42858 1/20 0.38
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP3A4 P08684 2/20 0.36
LMNA P02545 2/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
TP53 P04637 2/20 0.35
MAPK1 P28482 1/20 0.35
HPGD P15428 1/20 0.35
ALDH1A1 P00352 2/20 0.34
NPC1 O15118 1/20 0.34
NAAA Q02083 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4609411 0.80 BACE1 (0.49) LMNAHCRTR1HCRTR2HPGDALDH1A1
SCHEMBL13806872 0.78 ALDH1A1 (0.42) TSHRHTTLMNATP53HPGD
SCHEMBL5880146 0.75 ALDH1A1 (0.44) TSHRLMNATDP1L3MBTL1TP53
SCHEMBL4610471 0.73 LMNA (0.46) TSHRSMN1; SMN2LMNAL3MBTL1TP53
SCHEMBL12418029 0.70 LMNA (0.55) TSHRCYP1A2CYP2C19SMN1; SMN2CYP3A4
SCHEMBL6489038 0.70 MAPT (0.51) TSHRCYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL8131345 0.69 CYP1A2 (0.42) CYP1A2CYP2C19ALDH1A1
SCHEMBL7046306 0.69 HPGD (0.33) HPGD
SCHEMBL6779096 0.69 ALDH1A1 (0.54) TSHRHTTSMN1; SMN2LMNAMAPT
SCHEMBL15608309 0.68 BACE1 (0.41) HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050107448-A1 Calcium receptor antagonists JAPAN TABACCO INC. 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107448-A1 Calcium receptor antagonists CASR, CALCR, CALCRL TSHR 35/4885HTT 4314/4885CYP1A2 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.